3rd Division of General Surgery, Spedali Civili di Brescia, P.le Spedali Civili 1, Brescia, Italy.
Department of Clinical and Experimental Sciences, Surgical Clinic, University of Brescia, Brescia, Italy.
Surg Endosc. 2019 Jan;33(1):126-134. doi: 10.1007/s00464-018-6282-1. Epub 2018 Jun 22.
Detecting small nodules that are grossly unidentifiable remains a major challenge in liver resection for cancer. Novel developments in navigation surgery, especially indocyanine green (ICG)-based fluorescence imaging, are making a clear breakthrough in addressing this issue. ICG is almost routinely administered during the preoperative stage in hepatobiliary surgery. However, its full potential has yet to be realized, partly because there are no precise guidelines regarding the optimal dose or timing of ICG injections before liver surgery. The main goal of this study was to design an algorithm for the management of ICG injections to achieve optimal liver staining results.
Twenty-seven consecutive, unselected patients undergoing liver resection for cancer were enrolled and underwent preoperative liver function assessment by the LiMON test. Extra ICG i.v. injections at different doses and timings were performed. In vivo intraoperative analysis of the stain detected by near-infrared fluorescence imaging of the liver and ex vivo analysis of each resected nodule was performed and compared to the pathological analysis.
(i) The success rate of ICG injections in terms of liver staining was 92.6%; (ii) in the absence of or with 7 or more days from a previous ICG injection, the best dose to inject before the operation was 0.2 mg/kg, and the best timing was between 24 and 48 h before the scheduled surgery; and (iii) the ICG fluorescence patterns observed in the tumors were total fluorescence staining (41% of the cases), partial fluorescence staining (15%), rim fluorescence staining surrounding the tumor (30%), and no staining (15%).
This study is a building block for the characterization of liver nodules and the search for additional surface lesions undetected by preoperative radiological work-up-a crucial task for the successful treatment of liver cancer at an early stage using a safe, minimally invasive, and inexpensive technique.
在癌症的肝切除术中,检测大体上无法识别的小结节仍然是一个主要挑战。导航手术的新进展,特别是基于吲哚菁绿(ICG)的荧光成像,在解决这个问题方面取得了明显的突破。在肝胆外科手术中,ICG 几乎在术前阶段常规给药。然而,其全部潜力尚未得到充分发挥,部分原因是在肝手术前,关于 ICG 注射的最佳剂量或时间尚无精确的指南。本研究的主要目的是设计一种 ICG 注射管理算法,以实现最佳的肝染色效果。
连续纳入 27 例接受肝癌切除术的患者,并进行 LiMON 测试的术前肝功能评估。在不同剂量和时间进行额外的 ICG 静脉注射。对肝的近红外荧光成像检测到的染色进行体内术中分析,并对每个切除的结节进行离体分析,并与病理分析进行比较。
(i)ICG 注射在肝染色方面的成功率为 92.6%;(ii)在没有或距上次 ICG 注射 7 天以上的情况下,手术前最佳注射剂量为 0.2mg/kg,最佳注射时间为术前 24-48 小时;(iii)在肿瘤中观察到的 ICG 荧光模式为全荧光染色(41%的病例)、部分荧光染色(15%)、肿瘤周围的边缘荧光染色(30%)和无染色(15%)。
本研究为肝结节的特征描述以及寻找术前影像学检查未检测到的附加表面病变提供了基础,这是使用安全、微创和廉价技术早期成功治疗肝癌的关键任务。